Unlock stock picks and a broker-level newsfeed that powers Wall Street.

Stuttgart - Delayed Quote EUR

TherapeuticsMD, Inc. (29TA.SG)

Compare
0.8450
0.0000
(0.00%)
As of 8:00:23 AM GMT+2. Market Open.

Key Executives

Amounts are as of December 31, 2023 and compensation values are for the last fiscal year ending on that date. Pay is salary, bonuses, etc. Exercised is the value of options exercised during the fiscal year. Currency in EUR.
NameTitlePayExercisedYear Born
Governor Thomas G. Thompson Executive Chairman 141.07k -- 1942
Mr. Marlan D. Walker J.D. Chief Executive Officer 583.18k -- 1975
Mr. Joseph A. Ziegler Principal Financial & Accounting Officer 125.75k -- 1974
Mr. Douglas Steelman Vice President of Market Access -- -- --

TherapeuticsMD, Inc.

951 Yamato Road
Suite 220
Boca Raton, FL 33431
United States
561 961 1900 https://www.therapeuticsmd.com
Sector: 
Healthcare
Full Time Employees: 
1

Description

TherapeuticsMD, Inc. operates as a pharmaceutical royalty company in the United States. It has a license agreement with Mayne Pharma to commercialize the IMVEXXY, BIJUVA, and ANNOVERA prescription prenatal vitamin products sold under the BocaGreenMD and vitaMedMD brand names. The company sells its prescription pharmaceutical products and prenatal vitamin products through wholesale distributors and retail pharmacy distributors. TherapeuticsMD, Inc. was founded in 2008 and is headquartered in Boca Raton, Florida.

Corporate Governance

TherapeuticsMD, Inc.’s ISS Governance QualityScore as of April 1, 2025 is 5. The pillar scores are Audit: 8; Board: 6; Shareholder Rights: 3; Compensation: 7.
Corporate governance scores courtesy of Institutional Shareholder Services (ISS) Scores indicate decile rank relative to index or region. A decile score of 1 indicates lower governance risk, while a 10 indicates higher governance risk.

Upcoming Events

May 8, 2025 at 10:59 AM UTC - May 12, 2025 at 12:00 PM UTC

TherapeuticsMD, Inc. Earnings Date

Recent Events